Martinez Bueno A, Molina MA, Fielding A, et al. Disruptive mutations in TP53 associate with survival benefit in a PARPi trial in ovarian cancer. ESMO 2017, abstract LBA42.
Preoperatieve intraveneuze of orale ijzersuppletie bij patiënten met colorectaal carcinoom
mei 2023 | Benigne hematologie, Chirurgie, Maag-darm-leveroncologie